Quick Answer
RIGEL PHARMACEUTICALS INC reported Diluted EPS of $19.48 per share for fiscal year 2025.
RIGEL PHARMACEUTICALS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $19.48 | +1867.7% |
| 2024 | $0.99 | +168.7% |
| 2023 | -$1.44 | +58.1% |
| 2022 | -$3.44 | -3027.3% |
| 2021 | -$0.11 | +38.9% |
| 2020 | -$0.18 | +55.0% |
| 2019 | -$0.40 | +69.7% |
| 2012 | -$1.32 | +2.9% |
| 2011 | -$1.36 | -288.9% |
| 2010 | $0.72 | +126.4% |
| 2009 | -$2.73 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.46 | +108.6% | -55.5% |
| June 30, 2025 | $3.28 | +5566.7% | +420.6% |
| March 31, 2025 | $0.63 | +234.0% | -10.0% |
| September 30, 2024 | $0.70 | +312.1% | +1266.7% |
| June 30, 2024 | -$0.06 | +84.2% | +87.2% |
| March 31, 2024 | -$0.47 | -487.5% | -42.4% |
| September 30, 2023 | -$0.33 | -200.0% | +13.2% |
| June 30, 2023 | -$0.38 | -375.0% | -375.0% |
- RIGEL PHARMACEUTICALS INC showed an increase of +1867.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, RIGEL PHARMACEUTICALS INC’s diluted eps has grown by 813.6% (from $2.73 per share (loss) to $19.48 per share).
- The most recent figure is from RIGEL PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: